Show simple item record

dc.contributor.authorKamanda, Martin I
dc.contributor.authorMuriithi, Ian M
dc.date.accessioned2018-01-18T08:36:57Z
dc.date.available2018-01-18T08:36:57Z
dc.date.issued2017
dc.identifier.citationKamanda MI, Mathenge MI. Simultaneous occurrence of five prothrombotic induced vaso-occlusive phenomena and focal nodular hyperplasia due to prolonged use of combined oral contraceptive pills. BJR Case Rep 2017; 3: 20170070.en_US
dc.identifier.urihttp://hdl.handle.net/11295/102375
dc.description.abstractThis is a rare case of a patient simultaneously presenting with five complications associated with the prolonged (5 years) use of combined oral contraceptives. The two main ingredients of combined oral contraceptives responsible for thromboembolism are estrogen (estradiol) and progestogen (progestin). Progestins are linked with occlusion of arteries while estrogens can induce both arterial and venous thrombosis. This case represents a patient with portal vein thrombosis, superior mesenteric vein thrombosis, coeliac artery occlusion, splenic and jejunal infarction and focal nodular hyperplasia.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.titleSimultaneous occurrence of five prothrombotic induced vaso-occlusive phenomena and focal nodular hyperplasia due to prolonged use of combined oral contraceptive pillsen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record